Silo pharma to present at psychedelic drug development conference

Englewood cliffs, nj, april 24, 2023 (globe newswire) -- silo pharma, inc.  (nasdaq: silo) (“the company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that james kuo, m.d., vice president of r&d, will speak at the 3rd annual psychedelic therapeutics and drug development conference being held may 15-16, 2023, in person, at the hilton san francisco airport bayfront in burlingame, ca.
SILO Ratings Summary
SILO Quant Ranking